AEYE Stock Analysis: AudioEye | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 87m USD | 12M Return: -40.2% | US0507342014 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 368K
Qual. Beats: 0
Rev. Trend: 98.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality
| Net Income: -4.58m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 5.31 > 1.0 |
| NWC/Revenue: 2.32% < 20% (prev 3.62%; Δ -1.30% < -1%) |
| CFO/TA 0.17 > 3% & CFO 5.86m > Net Income -4.58m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (12.5m) vs 12m ago 0.35% < -2% |
| Gross Margin: 78.35% > 18% (prev 79.16%; Δ -0.81% > 0.5%) |
| Asset Turnover: 122.1% > 50% (prev 112.8%; Δ 9.30% > 0%) |
| Interest Coverage Ratio: -4.44 > 6 (EBIT TTM -4.31m / Interest Expense TTM 972k) |
| A: 0.03 (Total Current Assets 16.3m - Total Current Liabilities 15.3m) / Total Assets 34.9m |
| B: -3.06 (Retained Earnings -106.9m / Total Assets 34.9m) |
| C: -0.13 (EBIT TTM -4.31m / Avg Total Assets 34.4m) |
| D: 0.10 (Book Value of Equity 3.22m / Total Liabilities 31.7m) |
| Altman-Z'' = -10.54 = D |
| DSRI: 0.87 (Receivables 6.72m/7.06m, Revenue 42.0m/38.2m) |
| GMI: 1.01 (GM 79.16% / 78.35%) |
| AQI: 0.94 (AQ_t 0.52 / AQ_t-1 0.55) |
| SGI: 1.10 (Revenue 42.0m / 38.2m) |
| TATA: -0.30 (NI -4.58m - CFO 5.86m) / TA 34.9m) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of October 21, 2026, the stock is trading at USD 8.19 with a total of 272,108 shares traded. Over the past week, the price has changed by +17.17%, over one month by +18.35%, over three months by +23.72% and over the past year by -40.22%.
Current recommended Stop Loss: 7.70 (which is 6% or 1.3 ATR below the current price).
AudioEye has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy AEYE.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 17.3 | 111.6% |
P/E Forward = 5.9916
P/S = 2.0835
P/B = 27.8069
P/EG = 2.3727
Revenue TTM = 42.0m USD
EBIT TTM = -4.31m USD
EBITDA TTM = -341k USD
Long Term Debt = 15.6m USD (from longTermDebt, last quarter)
Short Term Debt = 906k USD (from shortTermDebt, last quarter)
Debt = 16.8m USD (corrected: LT Debt 15.6m + ST Debt 906k) + Leases 320k
Net Debt = 8.08m USD (calculated: Debt 16.8m - CCE 8.72m)
Enterprise Value = 95.6m USD (87.5m + Debt 16.8m - CCE 8.72m)
Interest Coverage Ratio = -4.44 (Ebit TTM -4.31m / Interest Expense TTM 972k)
EV/FCF = 16.40x (Enterprise Value 95.6m / FCF TTM 5.83m)
FCF Yield = 6.10% (FCF TTM 5.83m / Enterprise Value 95.6m)
FCF Margin = 13.88% (FCF TTM 5.83m / Revenue TTM 42.0m)
Net Margin = -10.92% (Net Income TTM -4.58m / Revenue TTM 42.0m)
Gross Margin = 78.35% ((Revenue TTM 42.0m - Cost of Revenue TTM 9.09m) / Revenue TTM)
Gross Margin QoQ = 78.84% (prev 78.20%)
Tobins Q-Ratio = 2.74 (Enterprise Value 95.6m / Total Assets 34.9m)
Interest Expense / Debt = 5.79% (Interest Expense 972k / Debt 16.8m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -3.41m (EBIT -4.31m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.06 (Total Current Assets 16.3m / Total Current Liabilities 15.3m)
Debt / Equity = 5.21 (Debt 16.8m / totalStockholderEquity, last quarter 3.22m)
Debt / EBITDA = -23.69 (negative EBITDA) (Net Debt 8.08m / EBITDA -341k)
Debt / FCF = 1.39 (Net Debt 8.08m / FCF TTM 5.83m)
Total Stockholder Equity = 4.21m (last 4 quarters mean from totalStockholderEquity)
RoA = -13.33% (Net Income -4.58m / Total Assets 34.9m)
RoE = -108.8% (Net Income TTM -4.58m / Total Stockholder Equity 4.21m)
RoCE = -21.80% (EBIT -4.31m / Capital Employed (Equity 4.21m + L.T.Debt 15.6m))
RoIC = -18.56% (negative operating profit) (NOPAT -3.41m / Invested Capital 18.4m)
WACC = 9.90% (E(87.5m)/V(104.3m) * Re(10.92%) + D(16.8m)/V(104.3m) * Rd(5.79%) * (1-Tc(0.21)))
Discount Rate = 10.92% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.99 | Cagr: 2.91%
[DCF] Terminal Value 73.13% ; FCFF base≈5.04m ; Y1≈5.78m ; Y5≈8.51m
[DCF] Fair Price = 7.36 (EV 100.5m - Net Debt 8.08m = Equity 92.5m / Shares 12.6m; r=9.90% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.31 | # QB: 0
Revenue Correlation: 98.64 | Revenue CAGR: 13.25% | SUE: 0.52 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.27 | Chg30d=+4.85% | Revisions=+50% | Analysts=3
EPS current Year (2026-12-31): EPS=0.99 | Chg30d=+4.97% | Revisions=+57% | GrowthEPS=+37.0% | GrowthRev=+8.2%
EPS next Year (2027-12-31): EPS=1.14 | Chg30d=+1.33% | Revisions=+29% | GrowthEPS=+15.5% | GrowthRev=+10.2%
[Analyst] Revisions Ratio: +64% (up=10, down=1)